Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00137202 · ClinicalTrials.gov registry record · NA
Post Burn Pruritus Study in Patients Undergoing Wound Healing
A NA study of Itching, sponsored by United States Army Institute of Surgical Research.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT00137202: Completed NA study of Itching, sponsored by United States Army Institute of Surgical Research.
NCT00137202 is a NA study of Itching that has completed, run by United States Army Institute of Surgical Research. The registered enrollment target is 36 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00137202, a NA study of Itching, has completed, sponsored by United States Army Institute of Surgical Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to see if a drug called ondansetron (Zofran) controls itching from healing burn wounds as well or better than the usual drug used, diphenhydramine (Benadryl).
Conditions Studied
Interventions
- DRUG Ondansetron (Zofran)
- DRUG Diphenhydramine (Benadryl)
Study Locations (1)
Texas
- US Army Institute of Surgical Research - Fort Sam Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2005-06 |
| Est. Completion | 2006-05 |
| Phase | NA |
What the finished NCT00137202 record still lists
NCT00137202 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Itching appearing as the primary indexed condition, and to 2 interventions - of which Ondansetron (Zofran) is the first listed.
NCT00137202 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT00137202 about?
NCT00137202 is a clinical study titled "Post Burn Pruritus Study in Patients Undergoing Wound Healing". The purpose of this study is to see if a drug called ondansetron (Zofran) controls itching from healing burn wounds as well or better than the usual drug used, diphenhydramine (Benadryl).
What is the current status of trial NCT00137202?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2005-06. Estimated completion is 2006-05.
What conditions does trial NCT00137202 study?
This clinical trial studies the following conditions: Itching.
What interventions are being tested in trial NCT00137202?
The interventions under investigation include: Ondansetron (Zofran) (DRUG), Diphenhydramine (Benadryl) (DRUG).
Who is sponsoring clinical trial NCT00137202?
This trial is sponsored by United States Army Institute of Surgical Research, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00137202 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Itching
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00137202's enrollment target sits among peer trials
36 1541st of 2000 higher than 437 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia